# clm_B8F364B1BB32

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 1,138,100,000 United States dollar  
valid_from: 2026-03-31  
valid_to: 2026-06-30  
published: 2026-05-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3B40C30B5BFE  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly operating income: 1,138,100,000 United States dollar", as of 2026-03-31 (until 2026-06-30). Claim clm_B8F364B1BB32, https://asof.is/claim/clm_B8F364B1BB32, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000173/0000875320-26-000173-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532026000173/0000875320-26-000173-index.htm (primary, SEC EDGAR 10-Q Q1 FY2026, published 2026-05-05)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_operating_income | 1,186,200,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_B8F364B1BB32](/claim/clm_B8F364B1BB32.md) | [clm_7EF8A5505C22](/claim/clm_7EF8A5505C22.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.